Jiangmen Central Hospital
Clinical trials sponsored by Jiangmen Central Hospital, explained in plain language.
-
New combo therapy aims to control advanced lung cancer longer
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. The approach combines low-dose radiation to the chest with chemotherapy and an immunotherapy drug (adebrelimab), followed by maintenance immunotherapy f…
Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
New combo therapy targets lung cancer fluid buildup
Disease control Not yet recruitingThis study tests whether combining the drug furmonertinib with chest radiation can help control EGFR-positive lung adenocarcinoma that has spread to the lining of the lung, causing fluid buildup. About 63 adults will receive the treatment, and researchers will track how long the …
Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated May 26, 2026 04:38 UTC